F. Roy MacKintosh

1.9k total citations
32 papers, 1.5k citations indexed

About

F. Roy MacKintosh is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, F. Roy MacKintosh has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in F. Roy MacKintosh's work include Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Immune Cell Function and Interaction (4 papers). F. Roy MacKintosh is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Immune Cell Function and Interaction (4 papers). F. Roy MacKintosh collaborates with scholars based in United States, United Kingdom and Italy. F. Roy MacKintosh's co-authors include Saul A. Rosenberg, Thomas V. Colby, Patrice Carde, Richard S. Schwartz, Peter L. Greenberg, Stanley L. Schrier, Jerome S. Burke, Esmail D. Zanjani, João L. Ascensão and Fred Rosenfelt and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

F. Roy MacKintosh

31 papers receiving 1.4k citations

Peers

F. Roy MacKintosh
Robert R. Chilcote United States
Theodore F. Beals United States
H. Behrendt Netherlands
Richard A. Rudders United States
Pascale Levine United States
James D. Cotelingam United States
Robert R. Chilcote United States
F. Roy MacKintosh
Citations per year, relative to F. Roy MacKintosh F. Roy MacKintosh (= 1×) peers Robert R. Chilcote

Countries citing papers authored by F. Roy MacKintosh

Since Specialization
Citations

This map shows the geographic impact of F. Roy MacKintosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Roy MacKintosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Roy MacKintosh more than expected).

Fields of papers citing papers by F. Roy MacKintosh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Roy MacKintosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Roy MacKintosh. The network helps show where F. Roy MacKintosh may publish in the future.

Co-authorship network of co-authors of F. Roy MacKintosh

This figure shows the co-authorship network connecting the top 25 collaborators of F. Roy MacKintosh. A scholar is included among the top collaborators of F. Roy MacKintosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Roy MacKintosh. F. Roy MacKintosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karnes, R. Jeffrey, F. Roy MacKintosh, Christopher H. Morrell, et al.. (2018). Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort. Frontiers in Oncology. 8. 296–296. 8 indexed citations
2.
Hall, Stephen W., et al.. (2017). Prediction of Adverse Events and Poor Prognosis by Low Abnormal Values.
3.
MacKintosh, F. Roy, Preston Sprenkle, Louise C. Walter, et al.. (2016). Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer. Frontiers in Oncology. 6. 157–157. 20 indexed citations
5.
Eisenberg, Peter D., F. Roy MacKintosh, Paul S. Ritch, Patricia A. Cornett, & A. Macciocchi. (2004). Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy:a dose-ranging clinical study. Annals of Oncology. 15(2). 330–337. 126 indexed citations
6.
MacKintosh, F. Roy, et al.. (2002). Sodium channel blocking (SCB) activity and transformation of paralytic shellfish toxins (PST) by dinoflagellate-associated bacteria. Aquatic Microbial Ecology. 29. 1–9. 19 indexed citations
7.
Almeida‐Porada, Graça, Ronald L. Brown, F. Roy MacKintosh, & Esmail D. Zanjani. (2000). Evaluation of Serum-Free Culture Conditions Able to Support the Ex Vivo Expansion and Engraftment of Human Hematopoietic Stem Cells in the Human-to-Sheep Xenograft Model. Journal of Hematotherapy & Stem Cell Research. 9(5). 683–693. 20 indexed citations
8.
Hall, Stephen W., et al.. (1999). Partial Thromboplastin Time. Archives of Internal Medicine. 159(22). 2706–2706. 31 indexed citations
9.
Pixley, John S., et al.. (1998). Prolonged Hematopoietic Chimerism in Normal Mice Transplanted in utero with Human Hematopoietic Stem Cells. Pathobiology. 66(5). 230–239. 8 indexed citations
10.
Almeida‐Porada, Graça, et al.. (1997). Transplantation of hematopoietic stem cells in utero. Stem Cells. 15(S2). 79–93. 64 indexed citations
11.
Pixley, John S., F. Roy MacKintosh, Elise Smith, & Esmail D. Zanjani. (1992). Anemia of Inflammation: Role of T Lymphocyte Activating Factor. Pathobiology. 60(6). 309–315. 1 indexed citations
12.
Zanjani, Esmail D., Maria G. Pallavicini, João L. Ascensão, et al.. (1992). Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero.. Journal of Clinical Investigation. 89(4). 1178–1188. 201 indexed citations
13.
Snyder, Harry W., David H. Henry, Gerald L. Messerschmidt, et al.. (1991). Minimal toxicity during protein a immunoadsorption treatment of malignant disease: An outpatient therapy. Journal of Clinical Apheresis. 6(1). 1–10. 20 indexed citations
14.
Jeor, Sachiko St., et al.. (1989). Nutrition education curriculum at the university of Nevada school of medicine. Journal of Cancer Education. 4(4). 235–240. 3 indexed citations
15.
Pixley, John S., et al.. (1989). Mechanism of Ranitidine Associated Anemia. The American Journal of the Medical Sciences. 297(6). 369–371. 15 indexed citations
16.
Schwartz, Richard S., F. Roy MacKintosh, Jerry Halpern, Stanley L. Schrier, & Peter L. Greenberg. (1984). Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer. 54(8). 1672–1681. 41 indexed citations
17.
MacKintosh, F. Roy, et al.. (1981). Methodologic problems in clonogenic assays of spontaneous human tumors. Cancer Chemotherapy and Pharmacology. 6(3). 205–10. 21 indexed citations
18.
Turner, Roderick R., Thomas V. Colby, & F. Roy MacKintosh. (1981). Testicular lymphomas: A clinicopathologic study of 35 cases. Cancer. 48(9). 2095–2102. 71 indexed citations
19.
MacKintosh, F. Roy & Eugene Bell. (1970). REVERSIBLE RESPONSE TO PUROMYCIN AND SOME CHARACTERISTICS OF THE UPTAKE AND USE OF AMINO ACIDS BY UNFERTILIZED SEA URCHIN EGGS. Biological Bulletin. 139(2). 296–303. 3 indexed citations
20.
MacKintosh, F. Roy & Eugene Bell. (1967). Stimulation of protein synthesis in unfertilized sea urchin eggs by prior metabolic inhibition. Biochemical and Biophysical Research Communications. 27(4). 425–430. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026